Viewing Study NCT02797795


Ignite Creation Date: 2025-12-24 @ 2:14 PM
Ignite Modification Date: 2026-02-22 @ 7:23 PM
Study NCT ID: NCT02797795
Status: UNKNOWN
Last Update Posted: 2021-03-03
First Post: 2016-06-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers
Sponsor: Neovia Oncology Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Cancer View
None Solid Tumors View
Keywords: